Javascript must be enabled to continue!
Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene
View through CrossRef
AbstractHemophilia is a genetic disease caused by a deficiency of blood coagulation factor VIII or IX. Bleeding into joints is the most frequent manifestation of hemophilia. Hemarthrosis results in an inflammatory and proliferative disorder termed hemophilic synovitis (HS). In time, a debilitating, crippling arthritis, hemophilic arthropathy, develops. Although the clinical sequence of events from joint bleeding to synovitis to arthropathy is well documented, the component or components in blood and the molecular changes responsible for hemophilic synovitis are not known. Iron has long been suspected to be the culprit but direct evidence has been lacking. Previously, we showed that iron increased human synovial cell proliferation and induced c-myc expression. Here we show that bleeding into a joint in vivo and iron in vitro result in increased expression of the p53-binding protein, mdm2. Iron induced the expression of mdm2 by normal human synovial cells approximately 8-fold. In a murine model of human hemophilia A, hemarthrosis resulted in pathologic changes observed in human hemophilic synovitis and a marked increase in synovial cell proliferation. Iron, in vitro, induced the expression of mdm2. The molecular changes induced by iron in the blood may be the basis of the increase in cell proliferation and the development of hemophilic synovitis. (Blood. 2004;104:2060-2064)
American Society of Hematology
Title: Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene
Description:
AbstractHemophilia is a genetic disease caused by a deficiency of blood coagulation factor VIII or IX.
Bleeding into joints is the most frequent manifestation of hemophilia.
Hemarthrosis results in an inflammatory and proliferative disorder termed hemophilic synovitis (HS).
In time, a debilitating, crippling arthritis, hemophilic arthropathy, develops.
Although the clinical sequence of events from joint bleeding to synovitis to arthropathy is well documented, the component or components in blood and the molecular changes responsible for hemophilic synovitis are not known.
Iron has long been suspected to be the culprit but direct evidence has been lacking.
Previously, we showed that iron increased human synovial cell proliferation and induced c-myc expression.
Here we show that bleeding into a joint in vivo and iron in vitro result in increased expression of the p53-binding protein, mdm2.
Iron induced the expression of mdm2 by normal human synovial cells approximately 8-fold.
In a murine model of human hemophilia A, hemarthrosis resulted in pathologic changes observed in human hemophilic synovitis and a marked increase in synovial cell proliferation.
Iron, in vitro, induced the expression of mdm2.
The molecular changes induced by iron in the blood may be the basis of the increase in cell proliferation and the development of hemophilic synovitis.
(Blood.
2004;104:2060-2064).
Related Results
Abstract 1234: Impact of cancer-associated mutations on MDM2 function
Abstract 1234: Impact of cancer-associated mutations on MDM2 function
Abstract
MDM2 is an E3 ubiquitin ligase that functions as a negative regulator of the tumor suppressor p53. MDM2 can promote the ubiquitination and proteasomal degra...
A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy
A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy
Repeated intra-articular hemorrhages lead to hemophilic arthropathy in severe hemophilia. Inflammation and pro-inflammatory cytokines (e.g., tumor necrosis factor alpha (TNFα)) mig...
Ribosomal Protein S4 X-Linked as a Novel Modulator of MDM2 Stability by Suppressing MDM2 Auto-Ubiquitination and SCF Complex-Mediated Ubiquitination
Ribosomal Protein S4 X-Linked as a Novel Modulator of MDM2 Stability by Suppressing MDM2 Auto-Ubiquitination and SCF Complex-Mediated Ubiquitination
Mouse double minute 2 (MDM2) is an oncoprotein that is frequently overexpressed in tumors and enhances cellular transformation. Owing to the important role of MDM2 in modulating p5...
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53
Previously, our group demonstrated that nuclear expression of E3 ubiquitin ligase (MDM2) in malignant pleural mesothelioma (MPM) is significantly associated with decreased overall ...
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
<div>Abstract<p>Overexpression of MDM2 has been related to oncogenesis. In this communication, we present evidence to show that MDM2 controls the cell cycle–dependent e...
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
<div>Abstract<p>Overexpression of MDM2 has been related to oncogenesis. In this communication, we present evidence to show that MDM2 controls the cell cycle–dependent e...
Abstract 1768: The oncogene Mdmx promotes genomic instability independent of p53.
Abstract 1768: The oncogene Mdmx promotes genomic instability independent of p53.
Abstract
Mdmx is upregulated in many human cancers. As a member of the Mdm2 protein family, Mdmx functions similar to Mdm2 as a negative regulator of the tumor suppr...
Abstract 638: PBF overexpression causes increased p53 ubiquitination and degradation via MDM2.
Abstract 638: PBF overexpression causes increased p53 ubiquitination and degradation via MDM2.
Abstract
The pituitary tumor-transforming gene-binding factor (PBF) is a relatively uncharacterised proto-oncogene, which is overexpressed in thyroid tumours. PBF el...

